Compare SIBN & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SIBN | BVS |
|---|---|---|
| Founded | 2008 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 778.8M | 783.2M |
| IPO Year | 2018 | 2016 |
| Metric | SIBN | BVS |
|---|---|---|
| Price | $18.91 | $14.00 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 3 |
| Target Price | ★ $23.88 | $14.00 |
| AVG Volume (30 Days) | 479.7K | ★ 809.1K |
| Earning Date | 05-11-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 41.33 | ★ 163.46 |
| EPS | N/A | ★ 0.52 |
| Revenue | $67,301,000.00 | ★ $568,087,000.00 |
| Revenue This Year | $16.95 | $7.52 |
| Revenue Next Year | $14.93 | $7.06 |
| P/E Ratio | ★ N/A | $26.76 |
| Revenue Growth | ★ 21.53 | N/A |
| 52 Week Low | $11.48 | $6.26 |
| 52 Week High | $21.89 | $15.89 |
| Indicator | SIBN | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 63.61 | 62.82 |
| Support Level | $18.34 | $7.20 |
| Resistance Level | $19.68 | $15.89 |
| Average True Range (ATR) | 0.73 | 0.79 |
| MACD | 0.05 | -0.03 |
| Stochastic Oscillator | 82.63 | 52.35 |
SI-BONE Inc is a medical device company that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ, and iFuse Bedrock Granite, which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.